Introduction
Reactive oxygen species (ROS), oxidative stress (OS) and periodontitis have together emerged as a case plagued with perplexities and maintenance of physiological levels of antioxidants (AO) seems to be the cure to it.
ROS, chemically reactive molecules containing oxygen, produced as a natural byproduct have formidable roles in cell signaling and homeostasis (1) . ROS includes oxygen derived free radicals, namely superoxide (O 2 * ), hydroxyl (OH * ), nitric oxide (NO), and non-radical derivatives of oxygen, namely hydrogen peroxide (H 2 O 2 ) and hypochlorous acid (HOCl).
Physiologically a state of dynamic stability prevails between ROS and antioxidants activity, which when shifts in favor of ROS, OS ensues. Oxidative stress leads to potential damage in the form of array of human diseases associated with hyper-inflammation such as arthritis, adult respiratory distress syndrome, heart diseases, stroke, acquired immunodeficiency syndrome (AIDS), Alzheimer's disease, Parkinson's disease (2) and periodontal diseases (3) .
Periodontitis, a chronic inflammatory disease of tooth supporting structures is characterized by gingival bleeding, periodontal pocket formation, destruction of connective tissue attachment and alveolar bone loss (4) . The emergence of pathogenic sub-gingival plaque biofilm and an inappropriate host response in a susceptible individual, results in progressive destruction of periodontal tissues leading to tooth loss (5) . Susceptibility appears largely due to a phenotype characterized by an exaggerated, ''hyper inflammatory'' response to the colonizing bacteria (6) . The production of ROS by polymorphonuclear leucocytes (PMN's) is the primary means of killing bacteria; however, the extracellular release of ROS results in destruction of the surrounding tissues (7, 8) .
Role of ROS in periodontal tissue destruction has been comprehensively discussed by Gustafson et al (9) , Panjamurthy et al (10) , Buduneli et al (11) and Akalin et al (12) . Excessive production of ROS can cause: lysis of cell membrane, inactivation of proteolytic enzyme inhibitors e.g. tissue inhibitor of matrix metalloproteinase (TIMP) and α-1 antiproteinase, activation of proteolytic enzymes such as collagenase, gelatinase and matrix metalloproteinase (MMP) resulting in collagenolysis (13) . ROS may also lead to stimulation of pro-inflammatory cytokine release via.activating nuclear factor-kβ (3). Thus, the larger upward shift in the pro-oxidant status, intracellularly, brings about direct damage to vital biomolecules, which ultimately causes cell death (by necrosis or accelerated apoptosis), and extracellularly cause direct connective tissue damage and destruction of extracellular matrices and their components (14) . However, it still remains a dilemma whether excess production of ROS in periodontitis patients is a cause or effect of the disease process.
It is estimated that 1-3 billion reactive species are generated per cell per day, therefore the importance of AO defense systems in the maintenance of health becomes clear (15) . Antioxidants are defined as those substances which when present at low concentrations, compared to those of an oxidizable substrate, will significantly delay or inhibit oxidation of that substrate (16) . Studies have shown that periodontitis patients have compromised anti oxidant defense in plasma (10, 17, 18) , saliva (3, 19) , GCF (17, 20) and gingival biopsy samples (21, 22) .
Oxidative killing of invading periopathogens leads to generation of highly toxic reactive oxygen metabolite (ROM) -the superoxide anion (O2 -* ). Superoxide anion formed, either dismutates spontaneously (a rapid reaction at pH 7.4) or is actively converted to hydrogen peroxide (H 2 O 2 ) by one of the three superoxide dismutase enzyme systems. SOD, a preventative, metal ion sequestrator, anti oxidant enzyme has been regarded as the most significant AO within mammalian tissues (23, 24) . SOD exists in three forms based on the associated co-factored metal ion namely SOD (30) reported that NSPT normalized the AO levels in GCF, saliva and serum.
There is a paucity of literature delineating the exact role of SOD in periodontal heath and disease. Hence, the aim of the present study is three fold: to assess the concentration of SOD in saliva and plasma (RBC lysate), to find the association, if any, with periodontal health and disease and to evaluate effectiveness of non surgical periodontal therapy(NSPT) in restoring physiological SOD levels.
II. Materials And Methods (A) Study groups and designs:
This longitudinal interventional human clinical study was undertaken by the Department of Periodontology & Department of Biochemistry, King George's Medical University, Lucknow, U.P. India. This study was performed in two sections. First, a cross-sectional study, to investigate the levels of salivary and plasma SOD activity in CP patients compared to healthy controls and second, a longitudinal interventional study, to investigate the effectiveness of non surgical periodontal therapy on local and systemic SOD activity in CP patients. The study protocol was carried out in accordance with the ethical standards outlined in the 1964 Declaration of Helsinki, revised in 2008. The Ethics committee, King George's Medical University, Lucknow, U.P, India approved the study protocol. Before initiating the study each patient was informed about the purpose and design of the study. An informed consent in the native language and a thorough medical and dental history was taken from all the participants.
A total of 50 systemically healthy subjects were divided into two groups-Group A and Group-B each having 25 subjects. Only Group A subjects received periodontal therapy and was followed up at 3 and 6 months period after the intervention. A total of 20 subjects in Group A completed the study, while in Group-B, 3 subjects were excluded from the study since they did not adhere to the pre sample collection protocol.
Inclusion criteria for Group-A were presence of clinical gingival inflammation, clinical attachment loss (CA loss) > 1mm, probing pocket depth (PPD) ≥ 4mm at 3-4 sites in more than 4 teeth in each quadrant and radiographic evidence of bone loss. Inclusion criteria for Group-B were absence of clinical gingival inflammation, PPD of < 3mm and CA loss of < 1 mm (31). Patients with history of any systemic diseases, smoking, use of tobacco in any form, alcoholism, pregnancy, presence of any gross pathology and also patients who have received any periodontal therapy in past 12 months or any antioxidant supplements, vitamin intake, anti-microbial, anti-inflammatory and immune suppressive therapy in the past 6 months were excluded.
Patients with less than 20 teeth present in the oral cavity, those who regularly used mouth wash and those who did not give their consent for the study were also excluded.
(B) Clinical Examination
All the clinical parameters were assessed after sample collection to avoid contamination of the samples. The readings were noted by a trained and calibered examiner (PP). For each patient, Plaque index (PI) (32) , Gingival index(GI) (33) , Probing pocket depth (PPD) and Clinical attachment loss (CA loss) were noted at 6 sites (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) on each tooth excluding third molars using a sterile Hu-Friedy (UNC-PCP15) probe. Reproducibility of data was checked and were found to be >90% accurate.
The independent variables of this study were; age, sex, education, income, and socio-economic status (SES), frequency of use of oral hygiene aid and number of teeth present in the oral cavity. Modified Prasad classification (34) was used to assess SES which divides it into 5 classes according to per capita monthly income.
(C)
Collection of clinical samples-All samples prior to and after NSPT, were collected the following morning after patients had fasted overnight. Patients were asked to refrain from brushing and drinking anything in the morning except water. Before sample collection, it was made sure that the individuals adhered to the aforementioned protocol.
(D)
Collection of saliva -Two milliliters of whole unstimulated saliva samples were collected by modified draining method for 5 min, Miller et al (35) . Saliva samples were centrifuged at 4000 rpm for 10 min to remove cell debris. The 0.5 ml of supernatant was stored in 1.5 ml aliquots, having a tracking number, at -80°C until analysis.
(E)
Collection of plasma -Two milliliters of blood was collected from the antecubital fossa by venipuncture using 20-gauge needle with a 5 ml syringe and transferred into purple top EDTA tube for plasma separation. Plasma samples were centrifuged at 2000 rpm at 4ºC for 20 minutes. 0.5 ml of extracted plasma was immediately transferred to 1.5 ml aliquots. Each aliquot was designated a tracking number and stored at -80°C until further analysis.
(F) Lysate Preparation-
Plasma was then transferred to separate sterile tubes. The pellet (RBC) was found intact in bottom of the tube, which was washed at least twice with normal saline (0.9%). Further, chilled distilled water was added equal to the amount of ruptured RBC separated. Now centrifugation at 10,000 rpm for 20 min was performed to collect the supernatant (lysate) and discard the pellet (cell debris). Lysate were stored at -80 º C until subjected to biochemical analysis.
(G) Estimation of Superoxide dismutase (SOD) (Mc Cord and Fridovich, 1969) (36)
Nicotinamidedinucleotide (NADH) in the presence of phenozinemethosulphate (PMS) generates superoxide radical which reduces the nitrobluetetrazolium (NBT) and form formazon having dark blue colour. When SOD source (saliva or RBC lysate) is added to above reaction mixture these participates in another reaction to neutralize O 2 ─ into H 2 O 2 and therefore first reaction; the reduction of NBTslows down and which indicates measure of the SOD activity. The unit of SOD enzyme activity is defined as the amount of enzyme required to inhibit the optical density at 560 nm of NBT reduction by 50% in 1 minute under the assay conditions. The results are expressed as unit per ml of lysate or saliva.
(H) Periodontal Intervention
In Group A, patients were subjected to full-mouth scaling and root planing by periodontal scalers and curettes (Hu-Friedy). The treatment consisted of four 45-minute sessions over a period of 3 weeks. Oral hygiene instructions were reinforced in each appointment. The patients were instructed to use only mechanical plaque removal methods i.e. toothbrushes and interdental cleaning aids during the study period, mouthwashes and /or antimicrobials were not prescribed during the study period. On first and second recall visits at 3 and 6 months respectively, sample collection and clinical parameter recording were again repeated and oral hygiene instructions were reinforced. For ethical reasons, subjects included in the study received nonsurgical and supportive periodontal treatment if necessary, after completion of the study.
III. Data Analysis
Descriptive statistics such as mean and standard deviation (SD) for continuous variables and frequency & percentage for categorical variables were determined. The categorical/dichotomous variables were compared by using Chi-square/Fisher exact test. The parameters at baseline were compared using the unpaired t-test and paired t-test was used to compare the changes in the parameters from baseline to 4 and 8 week. The correlation coefficient in Group-A was calculated among the parameters at baseline. The average percent change was calculated as (baseline value-follow-up value)/baseline X 100. The p-value <0.05 was considered as significant. All the analysis was carried out by using SPSS 16.0 version (Chicago, Inc. USA).
IV. Results
(A) Subject characteristics: Table 1 reveals no statistically significant differences (p>0.05) between the two groups in terms of independent variables.
(B) Cross sectional findings of the study:
All the clinical parameters (PI, GI, PPD and CA loss) were significantly higher in group A as compared to group B at baseline and the difference in their means was statistically significant (p<0.05). The samples in each group tested positive for SOD activity. At baseline, the mean SOD levels in saliva and plasma of group-A (19.36±8.40 U/ml, 24.60±8.62U/ml) were significantly lower when compared to group-B (36.22±9.53U/ml, 43.06±16.89U/ml) respectively and the intergroup difference in means were statistically significant (p<0.05) as depicted in Table 2 . Table 3 shows, significant negative correlation (p<0.01) between SOD levels in saliva (+1.000), PI, PPD & CA Loss (-0.708, -0.758 & -0.649) respectively. SOD levels in plasma showed significant negative correlation with PI and PPD (p<0.01). However, SOD levels in plasma and saliva had significant positive correlation (p<0.01) with each other.
(C) Longitudinal findings of the study:
Table-4 depicts that periodontal parameters improved significantly from baseline at both the recall visits in CP patients. The mean values of SOD saliva and SOD plasma at baseline were 19.36+8.40 & 24.60+8.62 U/ml respectively. Both the biochemical parameters showed a marked increase in their respective values at 3 months (29.04+9.58, 59.92+16.89U/ ml) and at 6 months (32.43+9.51, 66.79+15.63U/ml).
Figure-1 unveils a linear diagrammatic representation of average percent change in all the assessed parameters from baseline to 3 and 6 months. PPD decreased by 37.7% from baseline to 3 months and 60.5% from baseline to 6 months. CA Loss decreased by 12.2% from baseline to 3 months and 28.3% from baseline to 6 months. Salivary SOD levels increased upto 9.8% from baseline to 3 months and 25.7% from baseline to 6 months. The increase in plasma SOD from baseline to 4 week was 60.6% and at 6 months was 65.1%.
V. Discussion
Aerobic life is characterized by steady formation of ROS (37) which acts as a double edged sword as it is an essential component of the host response to insults such as periopathogens (38) and if kept unchecked damages critical bio-molecules such as proteins, lipids and DNA (39) . There has been absolutely no documented evidence investigating the whereabouts and potentiality of ROS as they have an abbreviated half life (14) . Hence the majority of research has focussed upon measuring the by-products arising from interaction between ROS and bio molecules such as lipids (Thiobarbituric acid reactive substances, TBARS in gingival biopsies: Halliwell & Whiteman (40) (19) .
In our study we opted to evaluate a specific AO profile, superoxide dismutase pertaining to the fact that total anti-oxidant capacity (TAOC) assays bear low sensitivities and may overlook the importance of an essential AO for a particular biological system. SOD has been localized within human periodontal ligament (13) and may represent an important defense mechanism within gingival fibroblasts against superoxide release (44) . The idea of selecting saliva as the medium for evaluation of SOD in our study stemmed from the fact that saliva may constitute the first line of defence against free radical mediated oxidative stress in oral cavity (45) .
The longitudinal study under consideration reveals no disparity (p>0.05) amongst the study population in terms of socio demographic characteristics ( Table-1 ). This was done to curtail the bias arising from ageing (46) . It is imperative to understand the SES of the study population in order to correlate its impact on periodontal health. The purpose of using Modified Prasad's classification is that it takes into consideration only the per capita monthly income as a variable and can be applied to both rural and urban populations. Smokers were excluded from the study keeping in view their negative impact over AO profile (47) .
At baseline, all the clinical parameters were found to be significantly higher in group-A than in group-B (p<0.05). Saliva being an extracellular fluid contains low levels of SOD but all the samples in this study tested positive showing the efficiency of the method used. Salivary SOD levels were noted to be significantly lower in CP group than in PH group (p<0.05). Our results are in accordance to studies by Singh et al, (30) they used SOD ELISA kit and found median salivary SOD levels to be 10.95 U/ml in chronic periodontitis subjects as compared to 21.66 U/ml in healthy controls. Trivedi et al, (48) reported lowest salivary SOD levels in diabetic, periodontally healthy subjects (13.45+2.80U/ml) and highest in healthy controls (29.64+6.98U/ml) however, SOD mean values in chronic periodontitis patients fell in between them (19.93+12.05 U/ml). On the contrary Wei et al, (29) revealed higher salivary SOD levels in CP patients (216.4+36.78U/mg protein) than controls (174.9+21.07) which they attributed to an overall increased oxidant status of CP group. Similar trend was noticed with plasma SOD concentration in CP group as compared to PH group (24.60+8.62U/ml, 43.60+16.89U/ml). Sobaniec and Sobaniec-Lotowska, (49) in an experimental study also found decreased serum SOD activity in perodontitis models. Our results are in harmony with Trivedi et al,(48), Singh et al, (30) and Baltaciog˘lu et al, (50) who also found decreased serum SOD levels in periodontitis patients (around 1.25 U/ml) than healthy controls (around 1.6 U/ml), least serum SOD levels were noted in post menopausal chronic periodontitis patients (about 1U/ml),. Contrasting results were found by Aziz et al, (51) who noted higher RBC SOD activity in CP subjects and Wei et al, (29) who noted similarly higher SOD levels in serum of CP patients. In periodontitis, primary acute host defense cells (PMN's) are activated as a two -stage process upon encountering periopathogens (P.gingivalis, A.actinomycetemcomitans) and their antigens, present in gingival sulcus or in the blood stream, consisting of priming and full scale activation. Primed neutrophils demonstrate elevated level of ROS which shifts the said ecological balance in favour of pro-oxidant species leading to increased utilization of SOD. Several observations about oxidant-antioxidant imbalance in the pathological process of periodontitis have been documented in literature. Ellis et al, (25) and Akalin et al, (52) found decreased gingival SOD activity in periodontitis groups than the matched controls. Chapple et al, (53) and Brock et al, (17) evaluated plasma TAOC and found it to be lower in periodontitis patients than of healthy controls.On the contrary, Kawamoto et al, (54) noted a decrease in the salivary TAOC over the course of menstrual cycle in women with periodontitis.
There has been absolutely no documented evidence in human studies correlating the local and systemic levels of SOD with periodontal clinical parameters which makes our study the first to report such correlation. We found a strong negative correlation (p<0.05) between salivary SOD and PI, PPD and CA loss (-0.708,-0.758,-0.649 respectively). We also noted a similarly strong negative correlation between plasma SOD, PI and PPD (+1.000, -0.666,-0.666). However, a strong positive correlation existed between plasma and salivary SOD which reflects systemic repercussions of periodontitis induced oxidative stress as supported in systematic review by Paraskevas et al, (55) who affirmed that chronic periodontitis induces a state of systemic inflammation. Ekuni D et al, (56) in an animal model demonstrated that periodontitis induced lipid peroxidation may be involved in the early stage of atheroscelorosis. On the contrary Esen C et al, (57) concluded that systemic OS is not affected by periodontitis.
Tamaki et al, (58) demonstrated a positive co-relation of serum reactive oxygen metabolite (ROM) with progression of periodontitis and an increase antibody titre towards P.gingivalis, P. Intermedia and E.corrodens. Pavlica et al, (59) in an animal study also found negative correlation between serum, GCF TAOC and clinical parameters.
The longitudinal aspect of our study involved treating CP patients with non surgical periodontal therapy (NSPT) and following them at 3 and 6 months to check for sustainability of results.We came across significant improvement in all the clinical parameters at 3 months and results were upheld till 6 months with an average percent change in PPD and CA loss of 60.5% and 28.3% respectively from baseline to 6 months. The SOD activity in saliva also experienced an upsurge from baseline to 6 months with change of 25.7%. A momentous improvement in SOD plasma levels were seen with a percent change of 65.1% at 6 months making our study stand out as the post treatment values outmatched those of healthy controls. Our results are in agreement with Singh et al, 2013 who reported insignificant improvement in serum and salivary SOD activity at 3 months after NSPT. Huang et al, (20) and Sukhtankar et al, (60) also reported improvement via. NSPT in the levels of respective AO studied. Toker et al, (61) and Grant et al, (28) noted no change in the AO profile studied. This finding in our study signifies the role of NSPT in reducing oxidative stress locally and systemically. This may be caused due to decreased bacterial load post NSPT thereby decreasing the prevailing inflammation,reducing ROS production and potentiating the body defence to restore the physiologic proantioxidant balance. Therefore it becomes inevitable to study the antioxidant defence profile which may further open doors for novel therapeutic approaches.
Within the constraints of this study it would not be erroneous to conclude that periodontitis negatively affects the level of SOD both locally as well as systemically predisposing the human body to oxidative stress associated disorders. Successful NSPT is highly effective in restoring SOD activity, hence defending its badge of the gold standard periodontal therapy. However, comprehensive large size longitudinal studies are needed which will further enhance our knowledge on SOD role in periodontal health & disease.
VI. Conclusion
These data suggest that SOD levels in saliva and plasma are compromised in periodontitis. SOD levels are correrelated with periodontal parameters delineating the importance of SOD in periodontal health. Non surgical periodontal therapy was able to restore the levels of SOD during follow-ups. 9 45 PI-Plaque index; GI-Gingival index; PPD-Probing pocket depth; CA Loss-Clinical Attachment Loss; **Significant at p<0.05 Values are in mean ± SD, 1 p<0.001 (significant from baseline), 2 p<0.001 (significant from 4 to 8 week)
